Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Stem Cells Transl Med ; 8(8): 775-784, 2019 08.
Article in English | MEDLINE | ID: mdl-31037833

ABSTRACT

Glaucoma is one of the leading causes of blindness, and there is an ongoing need for new therapies. Recent studies indicate that cell transplantation using Müller glia may be beneficial, but there is a need for novel sources of cells to provide therapeutic benefit. In this study, we have isolated Müller glia from retinal organoids formed by human induced pluripotent stem cells (hiPSCs) in vitro and have shown their ability to partially restore visual function in rats depleted of retinal ganglion cells by NMDA. Based on the present results, we suggest that Müller glia derived from retinal organoids formed by hiPSC may provide an attractive source of cells for human retinal therapies, to prevent and treat vision loss caused by retinal degenerative conditions. Stem Cells Translational Medicine 2019;8:775&784.


Subject(s)
Cell Transplantation/methods , Ependymoglial Cells/transplantation , Induced Pluripotent Stem Cells/cytology , Retinal Degeneration/therapy , Retinal Ganglion Cells/physiology , Animals , Cell Differentiation , Cell Line , Cells, Cultured , Ependymoglial Cells/cytology , Humans , Induced Pluripotent Stem Cells/transplantation , Organoids/cytology , Phenotype , Rats , Regeneration , Retinal Ganglion Cells/pathology
2.
ASN Neuro ; 11: 1759091419830186, 2019.
Article in English | MEDLINE | ID: mdl-30818968

ABSTRACT

There is intense interest and effort toward regenerating the brain after severe injury. Stem cell transplantation after insult to the central nervous system has been regarded as the most promising approach for repair; however, engrafting cells alone might not be sufficient for effective regeneration. In this study, we have compared neural progenitors (NPs) from the fetal ventricular zone (VZ), the postnatal subventricular zone, and an immortalized radial glia (RG) cell line engineered to conditionally secrete the trophic factor insulin-like growth factor 1 (IGF-1). Upon differentiation in vitro, the VZ cells were able to generate a greater number of neurons than subventricular zone cells. Furthermore, differentiated VZ cells generated pyramidal neurons . In vitro, doxycycline-driven secretion of IGF-1 strongly promoted neuronal differentiation of cells with hippocampal, interneuron and cortical specificity. Accordingly, VZ and engineered RG-IGF-1-hemagglutinin (HA) cells were selected for subsequent in vivo experiments. To increase cell survival, we delivered the NPs attached to a multifunctional chitosan-based scaffold. The microspheres containing adherent NPs were injected subacutely into the lesion cavity of adult rat brains that had sustained controlled cortical impact injury. At 2 weeks posttransplantation, the exogenously introduced cells showed a reduction in stem cell or progenitor markers and acquired mature neuronal and glial markers. In beam walking tests assessing sensorimotor recovery, transplanted RG cells secreting IGF-1 contributed significantly to functional improvement while native VZ or RG cells did not promote significant recovery. Altogether, these results support the therapeutic potential of chitosan-based multifunctional microsphere scaffolds seeded with genetically modified NPs expressing IGF-1 to promote repair and functional recovery after traumatic brain injuries.


Subject(s)
Brain Injuries, Traumatic/physiopathology , Brain Injuries, Traumatic/therapy , Brain/physiopathology , Microspheres , Neural Stem Cells/transplantation , Tissue Scaffolds , Animals , Cell Line , Chitosan , Disease Models, Animal , Ependymoglial Cells/metabolism , Ependymoglial Cells/transplantation , Genetic Engineering , Insulin-Like Growth Factor I/genetics , Insulin-Like Growth Factor I/metabolism , Male , Nerve Regeneration , Neural Stem Cells/metabolism , Neurogenesis , Rats, Sprague-Dawley , Rats, Transgenic , Recovery of Function , Stem Cell Niche
3.
Cir Cir ; 84(6): 454-458, 2016.
Article in Spanish | MEDLINE | ID: mdl-27133521

ABSTRACT

BACKGROUND: Autologous internal limiting membrane transplantation has allowed some cases of macular holes refractory to conventional surgery techniques to be treated. The purpose of this study is to describe the anatomical and functional outcomes of a modification of this technique in a case series of naïve macular hole patients. MATERIAL AND METHODS: A consecutive case series study was performed on patients with naïve macular holes with a diameter greater than 600 µ. Best corrected visual acuity, clinical features of the macular area, and optical coherence tomography were recorded before the operation and at the end of follow-up in all patients studied. All patients underwent 23 Ga core vitrectomy, posterior hyaloid separation, and brilliant-blue assisted internal limiting membrane peeling. A small piece of the internal limiting membrane was peeled off to make a free flap, and this was trasplanted and placed inside the macular hole under perfluorocarbon liquids. Air-fluid exchange was performed and SF6 gas was injected at a non-expansile concentration. RESULTS: The study included 5 eyes of 5 patients who underwent internal limiting membrane autograft. The mean age was 50.6 (SD 12.3) years. Four of the 5 cases had macular hole closure. The case where there was no closure of the macular hole was secondary to trauma. There was an improvement in visual acuity in all patients where the closing of the macular hole was achieved at the end of follow-up. CONCLUSIONS: In this cases series of macular hole patients, the autologous internal limiting membrane transplantation was associated with an anatomical closure of the macular hole and functional improvement in most of the patients studied.


Subject(s)
Free Tissue Flaps , Membranes/transplantation , Retinal Perforations/surgery , Adult , Astrocytes/transplantation , Ependymoglial Cells/transplantation , Female , Humans , Male , Middle Aged , Sulfur Hexafluoride , Tomography, Optical Coherence , Transplantation, Autologous , Treatment Outcome , Visual Acuity , Vitrectomy
4.
Stem Cells Transl Med ; 5(2): 192-205, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26718648

ABSTRACT

Human Müller glia with stem cell characteristics (hMGSCs) have been shown to improve retinal function upon transplantation into rat models of retinal ganglion cell (RGC) depletion. However, their translational potential may depend upon successful engraftment and improvement of retinal function in experimental models with anatomical and functional features resembling those of the human eye. We investigated the effect of allogeneic transplantation of feline Müller glia with the ability to differentiate into cells expressing RGC markers, following ablation of RGCs by N-methyl-d-aspartate (NMDA). Unlike previous observations in the rat, transplantation of hMGSC-derived RGCs into the feline vitreous formed aggregates and elicited a severe inflammatory response without improving visual function. In contrast, allogeneic transplantation of feline MGSC (fMGSC)-derived RGCs into the vitrectomized eye improved the scotopic threshold response (STR) of the electroretinogram (ERG). Despite causing functional improvement, the cells did not attach onto the retina and formed aggregates on peripheral vitreous remnants, suggesting that vitreous may constitute a barrier for cell attachment onto the retina. This was confirmed by observations that cellular scaffolds of compressed collagen and enriched preparations of fMGSC-derived RGCs facilitated cell attachment. Although cells did not migrate into the RGC layer or the optic nerve, they significantly improved the STR and the photopic negative response of the ERG, indicative of increased RGC function. These results suggest that MGSCs have a neuroprotective ability that promotes partial recovery of impaired RGC function and indicate that cell attachment onto the retina may be necessary for transplanted cells to confer neuroprotection to the retina. Significance: Müller glia with stem cell characteristics are present in the adult human retina, but they do not have regenerative ability. These cells, however, have potential for development of cell therapies to treat retinal disease. Using a feline model of retinal ganglion cell (RGC) depletion, cell grafting methods to improve RGC function have been developed. Using cellular scaffolds, allogeneic transplantation of Müller glia-derived RGC promoted cell attachment onto the retina and enhanced retinal function, as judged by improvement of the photopic negative and scotopic threshold responses of the electroretinogram. The results suggest that the improvement of RGC function observed may be ascribed to the neuroprotective ability of these cells and indicate that attachment of the transplanted cells onto the retina is required to promote effective neuroprotection.


Subject(s)
Ependymoglial Cells/transplantation , Retinal Degeneration/therapy , Retinal Ganglion Cells/transplantation , Animals , Cats , Cell Adhesion , Collagen/chemistry , Disease Models, Animal , Electroretinography , Ependymoglial Cells/cytology , Ependymoglial Cells/physiology , Humans , N-Methylaspartate , Neuroprotection , Primary Cell Culture , Retinal Degeneration/chemically induced , Retinal Degeneration/pathology , Retinal Degeneration/surgery , Retinal Ganglion Cells/cytology , Retinal Ganglion Cells/physiology , Stem Cell Transplantation , Stem Cells/cytology , Stem Cells/physiology , Tissue Scaffolds , Transplantation, Heterologous , Transplantation, Homologous , Vitrectomy , Vitreous Body/surgery
5.
Stem Cells ; 34(4): 997-1010, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26729510

ABSTRACT

Adult neurogenesis is tightly regulated by the neurogenic niche. Cellular contacts between niche cells and neural stem cells are hypothesized to regulate stem cell proliferation or lineage choice. However, the structure of adult neural stem cells and the contact they form with niche cells are poorly described. Here, we characterized the morphology of radial glia-like (RGL) cells, their molecular identity, proliferative activity, and fate determination in the adult mouse hippocampus. We found the coexistence of two morphotypes of cells with prototypical morphological characteristics of RGL stem cells: Type α cells, which represented 76% of all RGL cells, displayed a long primary process modestly branching into the molecular layer and type ß cells, which represented 24% of all RGL cells, with a shorter radial process highly branching into the outer granule cell layer-inner molecular layer border. Stem cell markers were expressed in type α cells and coexpressed with astrocytic markers in type ß cells. Consistently, in vivo lineage tracing indicated that type α cells can give rise to neurons, astrocytes, and type ß cells, whereas type ß cells do not proliferate. Our results reveal that the adult subgranular zone of the dentate gyrus harbors two functionally different RGL cells, which can be distinguished by simple morphological criteria, supporting a morphofunctional role of their thin cellular processes. Type ß cells may represent an intermediate state in the transformation of type α, RGL stem cells, into astrocytes.


Subject(s)
Ependymoglial Cells/cytology , Hippocampus/cytology , Neural Stem Cells/cytology , Neurogenesis , Animals , Biomarkers/metabolism , Cell Lineage/genetics , Cell Proliferation , Ependymoglial Cells/metabolism , Ependymoglial Cells/transplantation , Hippocampus/pathology , Humans , Mice , Neural Stem Cells/metabolism , Neural Stem Cells/transplantation
6.
Eur J Neurosci ; 39(10): 1704-17, 2014 May.
Article in English | MEDLINE | ID: mdl-24635194

ABSTRACT

Cell therapy for spinal cord injury (SCI) is a promising strategy for clinical application. Both bone marrow mesenchymal stromal cells (MSCs; also known as bone marrow-derived 'mesenchymal stem cells') and olfactory ensheathing cells (OECs) have demonstrated beneficial effects following transplantation in animal models of SCI. However, due to the large number of affecting parameters that determine the therapy success and the lack of methodological consensus, the comparison of different works is difficult. Therefore, we compared the effects of MSC and OEC transplants at early or delayed time after a spinal cord contusion injury in the rat. Functional outcomes for locomotion, sensory perception and electrophysiological responses were assessed. Moreover, the grafted cells survival and the amount of cavity and spared tissue were studied. The findings indicate that grafted cells survived until 7 days post-injection, but markedly disappeared in the following 2 weeks. Despite the low survival of the cells, MSC and OEC grafts provided tissue protection after early and delayed transplantation. Nevertheless, only acute MSC grafts improved locomotion recovery in treadmill condition and electrophysiological outcomes with respect to the other injured groups. These results, together with previous works, indicate that the MSC seem a better option than OEC for treatment of contusion injuries.


Subject(s)
Ependymoglial Cells/transplantation , Mesenchymal Stem Cell Transplantation , Spinal Cord Injuries/therapy , Spinal Cord/pathology , Spinal Cord/physiopathology , Animals , Cell Survival/physiology , Cells, Cultured , Disease Models, Animal , Ependymoglial Cells/physiology , Evoked Potentials, Motor/physiology , Female , Male , Motor Activity/physiology , Muscle, Skeletal/physiopathology , Neural Conduction/physiology , Olfactory Bulb/cytology , Rats, Sprague-Dawley , Recovery of Function/physiology , Reflex/physiology , Sensorimotor Cortex/physiopathology , Spinal Cord Injuries/pathology , Spinal Cord Injuries/physiopathology , Thermosensing/physiology , Touch/physiology
7.
J Neurochem ; 128(6): 829-40, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24117434

ABSTRACT

Müller cells constitute the main glial cell type in the retina where it interacts with virtually all cells displaying relevant functions to retinal physiology. Under appropriate stimuli, Müller cells may undergo dedifferentiation, being able to generate other neural cell types. Here, we show that purified mouse Müller cells in culture express a group of proteins related to the dopaminergic phenotype, including the nuclear receptor-related 1 protein, required for dopaminergic differentiation, as well the enzyme tyrosine hydroxylase. These dopaminergic components are active, since Müller cells are able to synthesize and release dopamine to the extracellular medium. Moreover, Müller-derived tyrosine hydroxylase can be regulated, increasing its activity because of phosphorylation of serine residues in response to agents that increase intracellular cAMP levels. These observations were extended to glial cells obtained from adult monkey retinas with essentially the same results. To address the potential use of dopaminergic Müller cells as a source of dopamine in cell therapy procedures, we used a mouse model of Parkinson's disease, in which mouse Müller cells with the dopaminergic phenotype were transplanted into the striatum of hemi-parkinsonian mice generated by unilateral injection of 6-hydroxydopamine. These cells fully decreased the apomorphine-induced rotational behavior and restored motor functions in these animals, as measured by the rotarod and the forelimb-use asymmetry (cylinder) tests. The data indicate local restoration of dopaminergic signaling in hemi-parkinsonian mice confirmed by measurement of striatal dopamine after Müller cell grafting.


Subject(s)
Dopaminergic Neurons/transplantation , Ependymoglial Cells/transplantation , Parkinsonian Disorders/pathology , Parkinsonian Disorders/therapy , Animals , Cebus , Cell Differentiation/physiology , Cells, Cultured , Corpus Striatum/cytology , Corpus Striatum/physiology , Disease Models, Animal , Dopamine/metabolism , Dopaminergic Neurons/cytology , Dopaminergic Neurons/metabolism , Ependymoglial Cells/cytology , Ependymoglial Cells/metabolism , Female , Mice , Mice, Inbred C57BL , Mice, Transgenic , Motor Activity/physiology , Nuclear Receptor Subfamily 4, Group A, Member 2/metabolism , Parkinsonian Disorders/metabolism , Phosphorylation/drug effects , Phosphorylation/physiology , Recovery of Function/physiology , Tyrosine 3-Monooxygenase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...